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Summary
In Drosophila, posterior deposition of oskar (osk)
mRNA in oocytes is critical for both pole cell and abdo-
men formation. Exon junction complex components,
translational regulation factors, and other proteins
form an RNP complex that is essential for directing
osk mRNA to the posterior of the oocyte. Until now,
it has not been clear whether the mRNA degradation
machinery is involved in regulating oskmRNA deposi-
tion. Here we show that Drosophila decapping protein
1, dDcp1, is a posterior group gene required for the
transport of oskmRNA. In oocytes, dDcp1 is localized
posteriorly in an osk mRNA position- and dosage-
dependent manner. In nurse cells, dDcp1 colocalizes
with dDcp2 and Me31B in discrete foci that may be re-
lated to processing bodies (P bodies), which are sites
of active mRNA degradation. Thus, as well as being a
general factor required for mRNA decay, dDcp1 is an
essential component of the osk mRNP localization
complex.
Introduction
During Drosophila oogenesis, Osk is localized to the
posterior end of the oocyte, where it nucleates polar
granules and is both necessary and sufficient for abdo-
men and pole cell formation (Ephrussi et al., 1991; Kim-
Ha et al., 1991; Ephrussi and Lehmann, 1992). oskmRNA
is synthesized in nurse cells, forming a translationally
repressed mRNP complex, and is transported to the
oocyte (reviewed in Wilhelm and Smibert, 2005). Once
in the oocyte, an intact microtubule network, as well as
Staufen (Stau) and Kinesin heavy chain (Khc) motor pro-
tein, guides osk mRNA to the posterior end (St Johnston
et al., 1991; Clark et al., 1994; Brendza et al., 2000).
The posterior localization of osk is mediated by vari-
ous components, including the splicing and transla-
tional machinery. Exon junction complex components,
such as Mago-nashi and Drosophila Y14/Tsunagi, inter-
act with eIF4AIII and Barentsz (Btz), and are required for
osk localization (Newmark and Boswell, 1994; van
Eeden et al., 2001; Hachet and Ephrussi, 2001; Mohr
et al., 2001; Palacios et al., 2004). Cup, a Drosophila
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en%5Cchou_tb_en.htmeIF4E binding protein that colocalizes with both Btz
and Ypsilon Schachtel (Yps), is a repressor of osk
mRNA translation via its interaction with the transla-
tional repressor Bruno and regulates osk localization
(Wilhelm et al., 2003; Nakamura et al., 2004). In addition,
Exuperantia (Exu) can directly interact with Yps and
forms an mRNP complex containing osk (Wilhelm
et al., 2000). Yps is a Y box protein that antagonizes
the stimulation of translation of osk mRNA by Oo18
RNA binding (Orb) (Mansfield et al., 2002). Orb mediates
the cytoplasmic polyadenylation of osk mRNA (Chang
et al., 1999; Castagnetti and Ephrussi, 2003) and inter-
acts with Exu and Yps in an RNA-dependent manner
(Mansfield et al., 2002). Although the role of Exu in osk
mRNA localization is not yet fully understood, its inter-
action with Yps and Orb implies a fine integration be-
tween transportation and translational regulation.
There is currently little evidence for the involvement of
the mRNA degradation machinery in the posterior local-
ization of osk. Saccharomyces cerevisiaeDhh1p, whose
Drosophila homolog Me31B is a component of the osk
mRNP complex, is an activator of decapping and phys-
ically interacts with Dcp1p (Coller et al., 2001). In addi-
tion, mammalian Staufen 1 interacts with the non-
sense-mediated decay factor Upf1 and directs the
decay of ADP-ribosylation factor 1 mRNA in a novel
mRNA decay pathway (Kim et al., 2005). Given that Dro-
sophilaStau is required for the posterior transport of osk
mRNA, it is possible that components of the mRNA deg-
radation machinery can participate in the osk mRNP
complex.
Eukaryotic polyadenylated mRNA can be degraded
primarily by removal of the 30 poly(A) tail, followed either
by decapping and 50 to 30 exonucleolytic digestion, or by
30 to 50 exosome degradation (reviewed in Parker and
Song, 2004). The cleavage of the 50 cap structure repre-
sents a critical step in mRNA degradation and turnover.
The two conserved eukaryotic decapping proteins,
Dcp1 and Dcp2, function together as a holoenzyme.
Dcp2 has been found to be the catalytic subunit but it
is unclear whether Dcp1 also has intrinsic catalytic activ-
ity. The current model is that Dcp1 enhances the de-
capping activity of Dcp2, but by a currently unresolved
mechanism (Beelman et al., 1996; Van Dijk et al., 2002;
Lykke-Andersen, 2002; Wang et al., 2002; Steiger
et al., 2003). In the cytosol, Dcp1 localizes in distinct
foci with other proteins involved in 50 to 30 mRNA decay,
including Dcp2, Dhh1, Edc3, the Lsm1-7 complex, and
the 50 to 30 exonuclease Xrn1 (reviewed in Fillman and
Lykke-Andersen, 2005). These foci are referred to as
processing bodies (P bodies), which are sites of active
mRNA degradation in yeast and mammalian cells (Sheth
and Parker, 2003; Cougot et al., 2004).
RNAi studies indicate that dDcp1 is involved in the
miRNA degradation pathway but not in nonsense-medi-
ated mRNA decay in S2 cells (Gatfield and Izaurralde,
2004; Rehwinkel et al., 2005). However, not much more
is known about the cytoplasmic localization of dDcp1
and/or its potential role(s) during development. Here,
we characterize a Drosophila Dcp1 mutation and
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show that dDcp1 is required for the proper degradation
of osk, bcd, and twe in the embryo and, as a component
of the osk mRNP complex, that it is specifically re-
quired for the posterior localization of osk mRNA in
the oocyte. In nurse cell cytoplasm, dDcp1 colocalizes
with dDcp2 (Drosophila decapping protein 2) and
Me31B in discrete foci. Also, dDcp1 is required for the
proper posterior localization of Exu, Yps, and Orb. In
conclusion, as a decapping factor, dDcp1 is required
not only for the degradation of osk mRNA during em-
bryogenesis but also for its cytoplasmic transportation
during oogenesis.
Results
dDcp1 Is a Posterior Group Gene
The b53 mutation was recovered from a screen for zy-
gotic lethal mutations with specific maternal effects. A
P transposase-insensitive cFRT2L2R second chromo-
some (see details in Experimental Procedures) was
used as the direct target for the P{lArB} and P{PZ} muta-
tors on the X chromosome. Four hundred fifty-six inde-
pendent insertions on the cFRT2L2R chromosome were
obtained from 768 P{lArB} and 232 P{PZ} transpositions.
Among them, 113 homozygous lethal mutations were
examined for their germline clone (GLC) phenotypes.
The P{lArB}-induced b53 mutation was isolated from
the 46 lines with specific maternal effects.
Homozygous b53 individuals show a pleiotropic lethal
phase ranging from embryonic lethality to weakly surviv-
ing adults. Among embryos derived from females with
b53 germline clones,w10% exhibit an abdominal dele-
tions phenotype as well as deformed anterior structures
when compared with wild-type (Oregon R) embryos
(Figures 1A and 1B); the remaining 90% die before cuti-
cle formation. The abdominal phenotype suggests that
the b53 mutation may affect a posterior group gene. Us-
ing inverse PCR and plasmid rescue, the position of the
single P{lArB}b53 insertion was determined (Figure 1J).
After the b53 chromosome was treated with transpo-
sase again, 52 viable wild-type revertants were recov-
ered from 112 independent lines, thus confirming that
the b53 mutant phenotype is caused by the P element
insertion.
The position of the P element insertion in the genomic
sequence suggested that the b53 mutant phenotypes
may result from the disruption of CG11183 and/or
CG5602. Transgenic flies carrying different genomic
fragments (T1–T5) were established (Figure 1J). Both
the T1 and T2 fragments, which span the region contain-
ing CG11183, can fully rescue the b53 mutant pheno-
types (see Table S1 in the Supplemental Data available
with this article online). This suggests that CG11183,
but not CG5602, is most likely disrupted by the P inser-
tion, as CG5602 is not completely contained within the
T2 fragment (Figure 1J). Unexpectedly, the T3 trans-
gene, which contains both the full-length CG5602 and
a truncation of CG11183, is able to rescue the lethality
of the b53 mutation. However, the rescued b53/b53;
T3/MKRS flies show partial female sterility with a typical
posterior group embryonic phenotype (Figure 1C and
see below). From these results, we conclude that the
posterior group embryonic phenotype of the b53mutation is caused by the P element-mediated disrup-
tion of the CG11183 gene.
We further evaluated the origin of the lethality associ-
ated with b53. We reasoned that the rescue of the b53
lethality by the T3 transgene may be due to the 22 kDa
N-terminal polypeptide of CG11183 contained within
the transgene (Figures 1J and 1K and see below). To
test this possibility, we constructed T4, which contains
a BsiWI frameshift mutation that eliminates the 22 kDa
polypeptide produced in T3 (Figure 1J). As expected,
this transgene cannot rescue the b53 lethality, although
a few barely viable but sterile adult homozygous flies
can survive (Table S1). We also constructed T5, which
contains an NheI frameshift mutation that disrupts the
CG5602 coding sequence in T3 (Figure 1J). T5 is ex-
pected to produce the 22 kDa polypeptide of CG11183
and a truncated form of the CG5602 protein. The T5
transgene rescues the b53 lethality, but the rescued fe-
males show a partial female sterility (Table S1). These
data indicate that, although the 22 kDa N-terminal poly-
peptide of CG11183 can rescue both the lethality and
the anterior phenotype, a possible effect of the b53 mu-
tation on CG5602 cannot be ruled out. Based on these
results, we confirm that the disruption of CG11183, but
not CG5602, is responsible for the posterior group phe-
notype of the b53 mutation.
A search of the databases revealed that the N-terminal
140 amino acids of CG11183 are highly conserved with
the decapping domains of decapping proteins such as
Dcp1p in S. cerevisiae and hDcp1a and hDcp1b in hu-
man (Figure 2A). However, their carboxy-terminal re-
gions are less conserved (Figure 2B). These homologs
all contain a putative EVH1/WH1 domain (Figure 2A)
which is a protein-protein interaction module (Ball
et al., 2002). Because CG11183 is the only Dcp1 homo-
log in the Drosophila genome, we refer to it as Drosoph-
ila decapping protein 1, or dDcp1.
The b53/b53;T3/MKRS individuals show a partial fe-
male sterile phenotype, with 60% of the embryos failing
to hatch. Among the unhatched embryos, more than
90% show a typical posterior group phenotype (Fig-
ure 1C) and the remaining 10% have a minor posterior
group phenotype. In addition to the abdominal pheno-
type, the pole cells are reduced in number (Figures 1F
and 1G) or totally missing (Figures 1H and 1I) compared
with wild-type (Figures 1D and 1E). This b53/b53;T3/
MKRS phenotype can be defined as due to the effect
of the P element insertion specifically on CG11183, after
eliminating the possible effect on CG5602 in the b53
chromosome, because the whole transcription unit of
CG5602 is included in the T3 fragment (Figure 1J). In ad-
dition, the T3 transgene in a wild-type background does
not generate any mutant phenotypes, suggesting that
the posterior group embryonic phenotype observed in
b53/b53;T3/MKRS individuals is not caused by any
dominant-negative effects of the N-terminal 22 kDa
polypeptide of CG11183 (Figure 1K). This view is further
strengthened by the absence of an embryonic pheno-
type when a 180 amino acid-containing N-terminal frag-
ment of dDcp1 was expressed by nanos-Gal4-driven
UASp-N180 (Figure 1J). Hence, the b53/b53;T3/MKRS
genotype provides a genetic background to specifically
and easily analyze the posterior group phenotype of the
b53 mutation. To simplify our description, we define the
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(A–C) Embryonic cuticle preparations. (A) Wild-type embryo showing eight abdominal segments and an intact anterior region. (B) Both a de-
formed anterior region and abdominal deletions can be seen in a b53 GLC embryo. (C) A typical abdominal deletion in a b53+T3 embryo.
(D–I) The embryonic pole cells at cellular blastoderm stained with anti-Vasa antibody (red). Compared with wild-type (D and E), the pole cells are
reduced in number or completely missing in b53+T3 embryos (F–I). (D, F, and H) DIC images. (E, G, and I) Confocal images.
(J) Schematic representation of the dDcp1 (CG11183) locus at polytene band 60A8, showing related genomic fragments and mutant alleles. The
P{lArB}b53 insertion is 46 bp downstream of the transcription start site and 27 bp upstream of the translation start site of CG11183, and 318 bp
upstream of the oppositely oriented CG5602. P{GSV6}11684 is located 35 bp upstream of the translation start site of CG11183. The deleted region
in dDcp1442P is shown. The T1–T5 and T2R57A transgenic fragments for complementation tests and related experiments, as well as the UASp-
N180 transgene, are shown.
(K and L) Western blot analyses. dDcp1 antibody specifically recognizes a 42 kDa band in wild-type extracts. (K) In a b53+T3 ovarian extract, the
42 kDa band is barely visible and a 22 kDa band corresponding to the N-terminal dDcp1 polypeptide encompassed by the T3 transgene is
marked by an asterisk. (L) The 42 kDa band cannot be detected in a dDcp1442P larval extract. a-tubulin was used as a loading control.b53/b53;T3/MKRS genotype as ‘‘b53 + T3’’ throughout
this paper.
Because there is still a residual amount of full-length
dDcp1 protein detectable in b53+T3 (Figure 1K), a null
allele is necessary for further analysis. From 450 impre-
cisely excised P{GSV6}11684 chromosomes, a dDcp1
protein null allele, dDcp1442P, was recovered. dDcp1442P
has a 274 bp deletion, within which a fragment of 28 ba-ses of unknown origin was inserted, extending from227
to +247 bp with respect to the translation start site (Fig-
ures 1J and 1L). dDcp1442P homozygous individuals die
as early pupae, and this lethality can be rescued by the
T2 transgene. It is difficult to examine osk mRNA depo-
sition in the dDcp1442P background because dDcp1442P
GLC females produce egg chambers that arrest by
stage 6 (data not shown). We therefore describe the
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604Figure 2. Sequence Alignment of dDcp1, hDcp1a, hDcp1b, and Dcp1p Decapping Proteins
(A) The N-terminal 140 amino acids of dDcp1, hDcp1a, and hDcp1b are conserved with full-length yeast Dcp1p. Conserved residues critical for
decapping function (D18 and R57) in Dcp1 are marked with asterisks. Seven b sheets and an a helix that form the EVH1/WH1 domain in Dcp1p are
indicated (She et al., 2004).
(B) The carboxy-terminal regions of dDcp1, hDcp1a, and hDcp1b are less well conserved.dDcp1 mutant phenotypes based on the b53 mutation
and b53+T3.
dDcp1 Is Required for osk mRNA Degradation
The yeast Dcp1p decapping protein is an essential com-
ponent of the 50 to 30 mRNA decay pathway. Loss of
Dcp1p leads to a complete block of decapping in vivo
(Beelman et al., 1996). The function of dDcp1 in mRNA
decay is supported by the genetic requirement for
dDcp1 in the degradation of osk and other maternal
mRNAs that were tested. In wild-type, the amount of
osk mRNA is greatly reduced at 2–3 hr after egg laying
(AEL) (Kim-Ha et al., 1991; Figure 3A1). In contrast, osk
mRNA is more stable and can still be detected 4–5 hr
AEL in b53 GLC embryos (Figure 3A2). This mRNA deg-
radation defect is most likely caused by the loss of
dDcp1 because the lethality of the b53 mutation can
be rescued by the dDcp1 wild-type transgene, T2 (see
above). Should CG5602 be responsible for the mRNA
degradation defect, we would expect a complete rescue
of this phenotype in b53+T3, which contains a wild-type
CG5602 transcript (Figure 1J). However, osk mRNA can
still clearly be detected 3–4 hr AEL in b53+T3 (Fig-
ure 3A3). But, the levels of mRNA detected are much
less than those in b53 GLC embryos. This partial rescueof the osk mRNA degradation defect suggests that
disruption of CG5602 is not the cause of the defect. In
contrast, the T2 transgene containing the full-length
CG11183 gene (Figure 1J) can completely rescue the de-
layed mRNA degradation phenotype in the b53mutation
(Figure 3A4). We have therefore confirmed that the
dDcp1 mutation is responsible for the delayed osk
mRNA degradation phenotype in b53 GLC embryos.
The partially rescued degradation defect observed in
b53+T3 may be due to the presence of the 22 kDa N-ter-
minal polypeptide of dDcp1 (Figure 1K), whose amino
acid sequence is highly conserved with the decapping
domains in the N-terminal regions of Dcp1 protein ho-
mologs (Figure 2A). To show that the putative decapping
function of dDcp1 is required for the proper decay of osk
mRNA, the R57 amino acid of dDcp1, which corre-
sponds to a residue previously shown to be critical for
Dcp1p and hDcp1a decapping activity (Tharun and
Parker, 1999; Lykke-Andersen, 2002), was mutated to
test its effect on osk mRNA degradation. We engineered
an altered T2 fragment containing a dDcp1 coding
sequence with an R57A substitution (Figure 1J). This
T2R57A transgene does not show any mutant phenotype
in a wild-type background, indicating that the R57A mu-
tation does not cause any dominant-negative effects. In
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mRNA Degradation in Early Embryogenesis
Northern blot analyses using osk (A1–A5),
bcd (B1–B5), and twe (C1–C5) probes.
(A1, B1, and C1) Normal maternal mRNA de-
gradation in wild-type embryos. (A1) osk,
(B1) bcd, and (C1) twe mRNAs are greatly re-
duced at 2–3 hr AEL.
(A2, B2, and C2) The degradation of maternal
mRNAs is impaired in b53 GLC embryos. (A2)
osk, (B2) bcd, and (C2) twe mRNAs remain
stable at 4–5 hr AEL.
(A3, B3, and C3) The degradation defects in
b53 GLC embryos are partially rescued by
the T3 transgene. (A3) osk, (B3) bcd, and
(C3) twe mRNAs can be detected at 3–4 hr
AEL in b53+T3 embryos, at least.
(A4, B4, and C4) The degradation defects in
b53 GLC embryos are completely rescued
by the T2 transgene. (A4) osk, (B4) bcd, and
(C4) twe mRNAs show extensive degradation
at 2–3 hr AEL in b53+T2 embryos.
(A5, B5, and C5) The degradation of maternal
mRNAs is impaired in 442P+T2R57A embryos.
(A5) osk, (B5) bcd, and (C5) twe mRNAs re-
main stable at 4–5 hr AEL. rp49 mRNA is
used as an internal loading control. One mi-
crogram of total embryonic RNA collected
at 1 hr intervals was loaded in each lane. Ge-
notype abbreviations: b53+T3: b53/b53;T3/
MKRS, b53+T2: b53/b53; T2/MKRS, 442P+
T2R57A: dDcp1442P/dDcp1442P; T2R57A/MKRS.addition, the levels of dDcp1R57A protein produced in
dDcp1442P/dDcp1442P; T2R57A/T2R57A ovaries are com-
parable to the wild-type dDcp1 protein levels (data not
shown). This suggests that the dDcp1R57A protein is sta-
ble when expressed. We therefore introduced theT2R57A
transgene into the dDcp1442P null background to deter-
mine whether the R57A single amino acid substitution in
dDcp1 is responsible for the osk mRNA degradation de-
fect. Our results show that osk mRNA in dDcp1442P/
dDcp1442P; T2R57A/MKRS embryos can still be detected
at 4–5 hr AEL (Figure 3A5), thus supporting the idea that
the decapping function of dDcp1 is responsible for the
regulation of osk mRNA degradation in embryogenesis.
We conclude that dDcp1 is a posterior group gene re-
quired for the proper degradation of osk mRNA.
We wanted to determine whether the degradation
function of dDcp1 is specific to osk. To test this, we ex-
amined the degradation of both bicoid (bcd), the anterior
determinant (Berleth et al., 1988), and twine (twe), the
cdc25 homolog uniformly distributed in the cytoplasm
of the early embryo (Alphey et al., 1992). These two
mRNAs are dramatically degraded at 2–3 hr AEL in
wild-type embryos (Edgar and Datar, 1996; Surdej and
Jacobs-Lorena, 1998; Figures 3B1 and 3C1). In b53
GLC embryos, both bcd and twe mRNAs can still be de-
tected 4–5 hr AEL (Figures 3B2 and 3C2). This degrada-
tion defect can be partially rescued in b53 + T3 embryos
(Figures 3B3 and 3C3) but can be fully rescued in
b53+T2 embryos (Figures 3B4 and 3C4). mRNA degra-
dation defects are also apparent in the dDcp1442P null
background containing the T2R57A transgene, with both
the bcd and twe mRNAs clearly detectable at 4–5 hr
AEL (Figures 3B5 and 3C5). Thus, dDcp1 is required
for the proper degradation of bcd and twe mRNAs andfunctions as a general degradation factor for maternal
mRNAs.
dDcp1 Is Localized at the Posterior Pole
of the Oocyte
A polyclonal dDcp1 peptide antibody was generated
which recognizes an expected 42 kDa band in a Western
blot of protein extracts from wild-type ovaries
(Figure 1K). In the ovarian protein extracts of b53+T3,
trace amounts of the 42 kDa band, as well as an extra
22 kDa band, were detected (Figure 1K). The 22 kDa
band represents the N-terminal 185 amino acids of
dDcp1 produced by the T3 transgene (Figure 1J). In
dDcp1442P, the 42 kDa band is undetectable in a larval
extract (Figure 1L). After stage 2 of oogenesis, dDcp1
protein is localized at the posterior pole of the oocyte
until stage 7 (Figures 4A–4C). At stage 8, dDcp1 tran-
siently accumulates at the anterior pole of the oocyte
and forms a ring structure (Figure 4D). This transient an-
terior accumulation pattern is similar to that of osk
mRNA (Ephrussi et al., 1991; Kim-Ha et al., 1991) and
other posteriorly localized components, such as Yps
(Wilhelm et al., 2000) and Btz (van Eeden et al., 2001). Af-
ter stage 9, dDcp1 is relocalized at the posterior cres-
cent and is maintained there until at least stage 10B (Fig-
ures 4E and 4F). This dDcp1 staining pattern was
reconfirmed using an HA-tagged dDcp1 fusion protein
(Figures 4G–4I).
dDcp1 Colocalizes with dDcp2 and Me31B
in the Nurse Cell Cytoplasm
The punctate staining of dDcp1 in the nurse cell cyto-
plasm is particularly obvious, especially at early stages
(Figures 4A–4C). These discrete cytoplasmic foci are
Developmental Cell
606Figure 4. Distribution of dDcp1 during Oo-
genesis
(A–F) Distribution pattern of dDcp1 in wild-
type egg chambers. In the oocyte, dDcp1 ac-
cumulates at the posterior end at (A) stages 2
and 3, (B) stage 5, and (C) stage 6. At (D) stage
8, dDcp1 is transiently localized at the ante-
rior end of the oocyte. At (E) stage 9 and (F)
stage 10, dDcp1 is localized to the posterior
pole of the oocyte. In nurse cells, dDcp1
can also be detected in discrete cytoplasmic
foci (arrow) at early stages (A–C).
(G–I) HA antibody staining in (G) stage 2, (H)
stage 8, and (I) stage 10A nanos-Gal4VP16;
UASp-HA-dDcp1 egg chambers.
(J–L) A stage 7 egg chamber expressing YFP-
dDcp1 was double stained for YFP (green)
and dDcp2 (red).
(M–O) A stage 7 egg chamber expressing
GFP-Me31B was double stained for GFP
(green) and dDcp1 (red).more visible in HA-dDcp1 (Figure 4G) and YFP-dDcp1
(Figure 4J) egg chambers and conspicuously resemble
the descriptions of P bodies (Sheth and Parker, 2003;
Cougot et al., 2004). We first examined whether dDcp1
can colocalize with Drosophila Dcp2 (dDcp2), encoded
by CG6169, using a dDcp2 antibody (see Experimental
Procedures). From early stages up to stages 8–9, the
dDcp2 antibody is able to recognize discrete sites in
both the cytoplasm and nuclei of nurse cells (Figures
S1A–S1C). At stage 10, dDcp2 cytoplasmic foci in the
nurse cells are greatly reduced, and staining is concen-
trated mainly in the nucleus. However, there is no enrich-
ment of dDcp2 at the posterior pole of the oocyte
(Figure S1D). These punctate foci of dDcp2 staining in
the nurse cell cytoplasm are greatly reduced in dDcp2
RNAi egg chambers, indicating that this antibody specif-
ically recognizes dDcp2 in nurse cells (Figures S1E and
S1F). As expected, YFP-dDcp1 colocalizes with the dis-
crete dDcp2 particles in the nurse cell cytoplasm (Fig-
ures 4J–4L). Furthermore, we also found that dDcp1
can colocalize with GFP-Me31B in the nurse cell cyto-
plasm (Figures 4M–4O). From these results, we propose
that these dDcp1/dDcp2/Me31B particles are the puta-
tive P bodies in the nurse cell cytoplasm.dDcp1 Specifically Affects the Posterior Deposition
of osk mRNA
In wild-type oocytes, osk mRNA is localized at the pos-
terior crescent (Figure 5A) and bcd mRNA forms an an-
terior ring structure (Figure 5C) at stage 10. In about
40% of b53GLC egg chambers, oskmRNA fails to local-
ize properly at the posterior pole, and in some cases osk
accumulates in nurse cells and at the anterior pole of the
oocyte (Figure 5B). However, localization of bcd mRNA
is not affected (Figure 5D). Gurken (Grk), the determinant
of dorsal follicle cell fate (Nilson and Schupbach, 1999),
is localized to the anteriodorsal corner in wild-type oo-
cytes (Figure 1E). Its distribution pattern is not affected
in b53 + T3 egg chambers (Figure 5F). Because both ab-
domen and pole cell formation are affected in dDcp1
mutant embryos, dDcp1would be predicted to be a pos-
terior group gene (reviewed in van Eeden and St John-
ston, 1999). We thus further examined the expression
patterns of Stau, Osk, and Vasa in the b53 + T3 back-
ground. In wild-type oocytes, Stau, Osk, and Vasa all ac-
cumulate in a crescent that is tightly localized to the pos-
terior pole of the oocyte after stage 9 (Figures 5G, 5I, and
5K). By contrast, in w60% of stage 9-10 mutant egg
chambers, the posterior localization of Stau is reduced
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tected faintly and diffusely in the middle ooplasm and
accumulates at the anterior cortex (Figure 5H). Osk
and Vasa staining is also dramatically reduced at the
posterior (Figures 5J and 5L). Moreover, dDcp1 does
not cause the precocious translation of osk mRNA
(data not shown). Collectively, these results indicate
that dDcp1 is a posterior group gene specifically re-
quired for the posterior deposition of osk mRNA.
The Localization of dDcp1 Is Dependent on osk
mRNA as Well as on Microtubule Organization
Because dDcp1 is required for the proper degradation of
several maternal mRNAs during embryogenesis (Fig-
Figure 5. Mutations in dDcp1 Specifically Affect the Posterior Depo-
sition of Maternal Determinants
(A–D) In situ hybridization of (A and B) osk and (C and D) bcd mRNA
in stage 10 egg chambers. The posterior localization of osk mRNA is
disrupted in a b53 GLC oocyte (B). The anterior localization of bcd
mRNA is unaffected in a b53 GLC oocyte (D).
(E–L) Immunostaining in stage 9-10 egg chambers. Compared with
the wild-type control (E), the anterior-dorsal Grk distribution is unaf-
fected in a b53+T3 oocyte (F). Compared with wild-type controls (G,
I, and K), the posterior localization of (H) Stau, (J) Osk, and (L) Vasa is
reduced or lost in b53+T3 oocytes. Note that in some cases, a faint
and diffuse Stau staining (H) can be detected in the b53+T3 oocyte.
The cell boundary was marked by Texas red phalloidin (red).ure 3), it is possible that dDcp1 affects the posterior lo-
calization of osk indirectly via its decapping function.
However, the R57A single amino acid substitution in
the decapping domain of dDcp1 does not disrupt the
posterior localization of osk mRNA in any egg chambers
examined (Figures S2A and S2B). Compared with wild-
type, the partially sterile dDcp1442P/dDcp1442P; T2R57A/
MKRS females (Table S1) do not show defects in pole
cell formation (Figures S2C–S2F) and do not have
a grandchildless phenotype. These observations clearly
rule out the above-mentioned possibility. Furthermore,
in dDcp1 mutations, the mislocalization of osk mRNA
could be an indirect consequence of the disorganization
of the microtubule network or reflect a direct require-
ment for dDcp1 for the proper formation of the osk
mRNP transportation complex. To investigate whether
microtubule cytoskeletal orientation is affected by
dDcp1, we examined the microtubule plus end using Ki-
nesin-lacZ (Clark et al., 1994) and the minus end using
Centrosomin (Li and Kaufman, 1996). Overall microtu-
bule organization and integrity were studied by examin-
ing the distribution of the microtubule binding protein
Tau-GFP (Micklem et al., 1997). In the b53+T3 oocyte,
posterior localization of Kinesin-lacZ (Figure S3B) and
localization of Centrosomin at the anterior cortex (Fig-
ure S3D), as well as the distribution pattern of Tau-
GFP (Figure S3F), are indistinguishable from wild-type
(Figures S3A, S3C, and S3E). Obviously, the requirement
of dDcp1 for osk mRNA posterior localization is not due
to an indirect effect on microtubule organization. Taking
all of these data together, it is more likely that dDcp1 is
directly involved in formation of the osk mRNP complex.
Stau, a dsRNA binding protein, interacts with osk
mRNA and directs its posterior deposition (Ramos
et al., 2000). It functions as an adaptor to transport osk
in a Khc-dependent manner (Brendza et al., 2000). As
suspected, HA-dDcp1 is colocalized with Stau at the
posterior end of the oocyte, and this colocalization is
maintained until at least stage 10 (Figures 6A–6C). In
both khc27 GLC and stauD3 mutant egg chambers,
dDcp1 is no longer localized to the posterior end and in-
stead accumulates at the anterior pole and the lateral
cortex of the oocyte (Figures 6D and 6E). This altered
spatial accumulation of dDcp1 in a khc mutant back-
ground is quite similar to that of osk mRNA (Brendza
et al., 2000). Should dDcp1 indeed be a component of
the osk mRNP complex, its level at the posterior pole
should be dependent on the dosage of osk. This was
confirmed by the excessive posterior localization of
dDcp1 in a genetic background containing two extra
copies of osk genomic sequences (Figure 6F). These
data further support the hypothesis that dDcp1 is a com-
ponent of the osk mRNP complex. As a component of
this complex, the localization of dDcp1 should be osk
mRNA dependent. This was shown by the anterior accu-
mulation of dDcp1 when osk mRNA was ectopically lo-
calized to the anterior pole using an osk-bcd-30UTR
hybrid mRNA (Figure 6G; Ephrussi and Lehmann,
1992). In both grk2B6/grkHF48 and par-16821/par-16323
mutant combinations, osk mRNA is mislocalized to the
center of the oocyte due to misorientation of the micro-
tubule network (Gonzalez-Reyes et al., 1995; Shulman
et al., 2000). In a grk2B6/grkHF48 mutant background,
dDcp1 can be deposited in the middle of the oocyte in
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dDcp1 Is osk mRNA Dosage and Position
Dependent, and Microtubule Organization
Dependent
(A–C) HA-dDcp1 (green) (A) is colocalized
with Stau (red) (B) in the posterior crescent
of the nanos-Gal4VP16; UAS-HA-dDcp1 oo-
cyte.
(D and E) dDcp1 (green) accumulates in the
anterior and lateral cortex in (D) khc27 GLC
and (E) stauD3 oocytes.
(F) The posterior localization of dDcp1 (green)
is increased in an oocyte carrying four copies
of the osk gene.
(G) dDcp1 (green) is ectopically localized to
the anterior (arrows) of an osk-bcd 30UTR
oocyte.
(H and I) dDcp1 (green) is mislocalized in
grk2B6/grkHF48 oocytes. The cell boundary is
marked by Texas red phalloidin (red) (I).
(J–L) dDcp1 (red) is mislocalized in par-16821/
par-16323; kin-lacZ/+ oocytes. The microtu-
bule plus end is labeled by Kinesin-lacZ
(green, anti-lacZ) (J and L).
HA-dDcp1 was detected by rat anti-HA anti-
body (A and C). dDcp1 was detected by rab-
bit anti-dDcp1 antibody (D–I, K, and L). Stage
9-10 egg chambers are shown in all panels.the same way as osk mRNA (Figures 6H and 6I). Simi-
larly, in par-16821/par-16323 mutant oocytes, dDcp1 is
mislocalized and colocalizes with a Kinesin-lacZ fusion
protein marking the plus end of microtubules (Figures
6J–6L). Altogether, these data clearly indicate that the
localization of dDcp1 is dependent on the organization
of microtubules and is determined by the position of
osk mRNA, which is similar to the behavior of other
osk mRNP complex components.
dDcp1 Is Required for the Posterior Localization
of Exu, Yps, and Orb
Among those proteins involved in osk mRNA localiza-
tion, Exu and dDcp1 have a similar spatial and temporal
distribution pattern in both nurse cells and the oocyte. In
the oocyte, each accumulates transiently at the anterior
pole and subsequently becomes localized to the poste-
rior pole (Mansfield et al., 2002; Figures 4D–4F). We
therefore suspected that dDcp1 can interact with Exu
and thus would be a new component of the large Exu-Yps mRNP complex. As expected, dDcp1 colocalizes
with GFP-Exu in the posterior pole of the stage 10 oo-
cyte (Figures 7A–7C). In addition, the punctate pattern
of dDcp1 clearly matches that of GFP-Exu in the nurse
cell cytoplasm of stage 9 egg chambers (Figures 7D–
7F). Exu is known to be a component of sponge bodies,
which are subcellular structures consisting of RNA and
ER-like cisternae embedded in an amorphous elec-
tron-dense mass (Wilsch-Brauninger et al., 1997). Taken
together with the facts that Exu colocalizes with dDcp1
(Figures 7D–7F) and dDcp1 colocalizes with both dDcp2
and Me31B (Figures 4J–4O), it will be interesting to clar-
ify whether the previously identified sponge bodies are
the putative P bodies in the nurse cell cytoplasm.
Genetically, dDcp1 is required for the posterior local-
ization of Exu and Yps. In a b53+T3 background, the
posterior localization of GFP-Exu after stage 9 is im-
paired (Figure 7M). Instead of its normal posterior local-
ization, Yps accumulates excessively at the anterior
pole in stage 10 b53+T3 oocytes (Figures 7K and 7N).
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(A–F) dDcp1 (red) is colocalized with GFP-Exu (green) in (A–C) the posterior end of the oocyte and (D–F) the cytoplasm of nurse cells.
(G–I) dDcp1 (green) is colocalized with Orb (red) at the posterior end of the oocyte in (G) stage 5, (H) stage 9, and (I) stage 10 egg chambers. In
addition, in early stage 9 egg chambers (H), dDcp1 is also colocalized with Orb at the anterior end of the oocyte.
(J–O) Compared with wild-type controls (J–L), the posterior localization of GFP-Exu (stage 9), Yps (stage 10), and Orb (stage 10) is disrupted in
b53+T3 mutant oocytes (M–O). Genotype used in (M): b53/b53; T3/GFP-Exu.
(P) GFP-Exu coimmunoprecipitates with dDcp1 in an RNase-sensitive manner. A GFP-Exu ovarian extract was immunoprecipitated using an
anti-GFP antibody. Western blotting was performed using an anti-dDcp1 antibody.
(Q) HA-dDcp1 coimmunoprecipitates with Yps. Ovarian extract from a4-tubulinGal4VP16; HA-dDcp1 females was immunoprecipitated using an
anti-HA antibody. Western blotting was performed using an anti-Yps antibody. In (P) and (Q), a wild-type (OR) ovarian extract was used as the
control. The input was 1/100 the volume of the ovarian extract used in the coimmunoprecipitation reaction.By contrast, the distribution patterns of Exu and Yps at
earlier stages are not affected (data not shown). By co-
immunoprecipitation, dDcp1 was found to interact with
GFP-Exu (Figure 7P) in an RNase-sensitive manner.
This RNase-sensitive interaction between dDcp1 and
Exu indicates a complex nucleated on the RNA. Simi-
larly, Yps can be coimmunoprecipitated with HA-dDcp1
(Figure 7Q). Combining the coimmunoprecipitation and
genetic data (Figures 6 and 7), we propose that dDcp1
and Exu are in the same osk mRNP complex, given
that the interaction between Exu and osk has been
reported (Wilhelm et al., 2000). Together with the obser-
vation that dDcp1 is colocalized with Exu in both nurse
cells and the oocyte during oogenesis (Figures 7A–7F),
and the requirement of dDcp1 for proper Exu and Yps
posterior localization (Figures 7M–7O), we conclude
that dDcp1 is a component of the osk-Exu-Yps mRNP
complex.
Orb interacts with Exu in an RNA-dependent manner
and functionally antagonizes Yps (Mansfield et al.,
2002). By coimmunostaining, dDcp1 was found to co-
localize with Orb in the oocyte from early stages to stage
9 (Figures 7G and 7H). The posteriorly localized dDcp1
continues to colocalize with Orb after stage 9 (Figure 7I),
although the anterior accumulation of dDcp1 is reduced.
We further examined whether the posterior localization
of Orb is also dDcp1 dependent. At stage 9, dDcp1 and
Orb remain colocalized in b53+T3mutant egg chambers
(data not shown). In the stage 10 mutant oocyte, Orb has
less posterior staining and accumulates mostly at theanterior cortex (Figure 7O) compared with wild-type
(Figure 7L). This implies that after stage 9, dDcp1 is re-
quired to recruit Orb into the posterior osk mRNP com-
plex so that Orb can activate translation. Nevertheless,
we cannot rule out the possibility that the recruitment
of Orb is osk mRNP complex dependent. Altogether,
these results provide evidence that dDcp1 in the osk-
Exu-Yps mRNP complex contributes to the posterior lo-
calization of osk mRNA and is genetically required for
the proper localization of Exu, Yps, and Orb.
Discussion
Our data reveal that the decapping factor dDcp1 is
a component of the osk mRNP complex. As such, the
presence of dDcp1 is expected to cause the degrada-
tion of osk mRNA. However, osk mRNA degradation
seems to be repressed until embryogenesis. How can
dDcp1 remain stably associated with its substrate with-
out initiating mRNA decay? First, the presence of dDcp1
in the osk mRNA complex may be independent of the
presence of dDcp2. Because it has been suggested
that Dcp1 and Dcp2 function together in vivo in a de-
capping holoenzyme with Dcp2 as the catalytic subunit,
Dcp1 alone should not constitute the active decapping
machinery (Beelman et al., 1996; Van Dijk et al., 2002;
Lykke-Andersen, 2002; Wang et al., 2002; Steiger
et al., 2003). Our observation of the lack of dDcp2 poste-
rior crescent staining in the oocyte after stage 9 sup-
ports this possibility (Figures S1C and S1D). Second,
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pressors of mRNA decay (Coller et al., 1998; Wilusz
et al., 2001; Khanna and Kiledjian, 2004). This is sup-
ported by the observation that the length of the osk
poly(A) tail ranges from 100 to 230(A) during its transpor-
tation (Chang et al., 1999; Castagnetti and Ephrussi,
2003). Third, eIF4E and the association of ribosomes
on mRNA can inhibit decapping activity (Schwartz and
Parker, 2000; Ramirez et al., 2002). During oogenesis,
osk mRNA is associated with polysomes even if it is
not yet posteriorly localized (Braat et al., 2004). This sug-
gests that a stable translational initiation complex is pre-
assembled with osk mRNA during its transportation and
consequently may be able to repress the decapping
function of dDcp1. These mechanisms may provide
a plausible explanation of an inhibitory system acting
during transportation and a degradation system that
can be activated or derepressed only after osk mRNA
is set for degradation at early embryogenesis.
Me31B, the Drosophila homolog of decapping activa-
tor Dhh1p in yeast, is involved in the translational re-
pression of osk mRNA and interacts with Exu in an
RNase-dependent manner (Nakamura et al., 2001).
Dhh1p physically interacts with Dcp1p and stimulates
mRNA decapping (Coller et al., 2001). Likewise, dDcp1
may interact with Me31B and repress the translation of
osk mRNA. However, in the b53 GLC and b53 + T3 egg
chambers examined, we could not observe any prema-
ture translation of oskmRNA (data not shown). Although
it is still not clear whether Me31B is also an activator for
decapping, Me31B can colocalize with dDcp1 in dis-
crete cytoplasmic foci in nurse cells (Figures 4M–4O).
Moreover, Me31B has been found to colocalize with
eIF4E and Cup (Wilhelm et al., 2003; Nakamura et al.,
2004), whereas mammalian eIF4E and the mammalian
homolog of Cup are located in P bodies (Ferraiuolo
et al., 2005; Andrei et al., 2005). Because dDcp1 is re-
quired for the degradation of several maternal mRNAs
(Figure 3) and is colocalized with dDcp2 (Figures 4J–
4L), we suggest that these discrete cytoplasmic foci in
nurse cells are the putative Drosophila P bodies. In ad-
dition to dDcp1, both Me31B and the polysomal appara-
tus are also components of the osk mRNP complex in
the oocyte (Nakamura et al., 2001; Braat et al., 2004)
and are components of the polar granules. Interestingly,
their counterparts, Dcp1p/hDcp1a, Dhh1p/Rck, and
eIF4E also reside in yeast and human P bodies (Sheth
and Parker, 2003; Cougot et al., 2004). The presence
of shared components suggests that polar granules
and P bodies are closely related structures. This raises
the possibility that a conversion between these two par-
ticles may exist during development.
Prior to localization, the translation of osk mRNA is re-
pressed. After stage 9, its translation is derepressed at
the posterior end of the oocyte. Considering the coexis-
tence of the translational repressors and activators of
osk mRNA at the posterior end of the oocyte at stage
10, it is possible that osk mRNA exists in a balance be-
tween translational repression and activation. Recently,
activators of mRNA decapping such as yeast Dhh1p and
mammalian RCK/p54 have been found to be transla-
tional repressors (Coller and Parker, 2005). These find-
ings led to a model in which the translational status of
a cytoplasmic mRNA is the consequence of competitionbetween the translational apparatus and the repression
apparatus (Coller and Parker, 2005). Furthermore, there
is also a reciprocal movement of mRNAs between poly-
somes and P bodies (Brengues et al., 2005). A dynamic
switch of mRNAs among translational activation, trans-
lational repression, and degradation is conceivable.
Considering that both dDcp1 and Me31B are evolution-
arily conserved decapping factors in P bodies and
are present in osk mRNP at stage 10, we would expect
that the status of osk mRNA can potentially shift from
translation repression to degradation. Nevertheless,
the majority of osk mRNA degradation occurs during
early embryogenesis instead of during oogenesis (Eph-
russi et al., 1991; Kim-Ha et al., 1991). Under these cir-
cumstances, the preassociation of the dDcp1/Me31B
decapping factors on the oskmRNP complex is presum-
ably not able to act as an active degradation machinery.
Together with the fact that dDcp1 does not have a trans-
lational repression function during oogenesis, we pro-
pose that the existence of dDcp1/Me31B on the osk
mRNP complex may contribute to the embryonic degra-
dation of osk mRNA. One possibility is that an unknown
factor can trigger the rapid degradation of osk mRNA at
the maternal-zygotic transition in early embryogenesis,
which is supported by the finding that Smaug is a trigger
of maternal hs83 mRNA degradation in embryos (Semo-
tok et al., 2005). Instead of assembling a degradation
complex de novo, the preincorporation of dDcp1/
Me31B may facilitate the degradation of osk mRNA dur-
ing the maternal-zygotic transition.
Experimental Procedures
Drosophila Stocks
The wild-type strain used is Oregon R (OR). Fly stocks were raised at
25ºC on standard cornmeal and agar medium. The following trans-
genic stocks were used in this study: P{w+; kinesin-LacZ }KZ503
(Clark et al., 1994); P{w+; Tau-GFP} (Micklem et al., 1997); P{w+;
GFP-Exu}NGE3 (Theurkauf and Hazelrigg, 1998); P{w+; GFP-Me31B}
(Nakamura et al., 2001); nanos-Gal4VP16 (Van Doren et al., 1998);
a4-tubulin-Gal4VP16 (a gift from N. Perrimon); P{osk+6.45} (Ephrussi
et al., 1991); P{osk-bcd 30UTR} (Ephrussi and Lehmann, 1992); and
P{GSV6}11684 (Drosophila Gene Search Project, Tokyo Metropolitan
University). We also used the following mutant alleles: stauD3,
par-16821, and par-16323 (Shulman et al., 2000); khc27 (Brendza
et al., 2000); grk2B6 and grkHF48 (Neuman-Silberberg and Schup-
bach, 1993). All other stocks used were provided by the Blooming-
ton Stock Center.
The P Transposase-Insensitive cFRT2L2R Chromosome
The FRT2L2R chromosome, containing P{hs-neo>>, ry+, FRT}40A on
2L and P{>whs>, FRT}42B on 2R (Chou and Perrimon, 1996), was
modified to become insensitive to P transposase after three consec-
utive transposase treatments. Four hundred twenty-seven indepen-
dent FRT2L2R chromosomes that showed no somatic transposition
based on lack of mosaicism in the eye were selected after two chal-
lenges with P transposase. Among these, 107 homozygous viable
lines with rosy eyes were recovered. These lines were then exam-
ined for their efficiency of germline clone (GLC) production. The
number of ovaries with developed vitellogenic egg chambers versus
the total number of ovaries was determined using the autosomal
FLP-DFS technique (Chou and Perrimon, 1996). Based on this anal-
ysis, the two most efficient chromosomes, with a 55%–85% GLC
efficiency for both the 2L and 2R arms, were selected for further
treatment. One chromosome remained insensitive after further P
transposase treatment, as its GLC efficiency ranged consistently
from around 55% to 85% for both arms in ten independent homozy-
gous viable progeny examined. The isogenized chromosome pro-
duced GLC-derived embryos that have a greater than 95% hatching
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did not create detectable lesions in this particular chromosome.
Originally, P{hs-neo>>, ry+, FRT}40A was inserted 30 to the T at po-
sition 240696 of the AE003781 clone, with the 30 end of the P element
closer to the centromere. In clippedP{hs-neo>>, ry+, FRT}40A, impre-
cise excision removes the 50 end of the P element and most of the
rosy coding sequences, that is, from base 26 to approximately
base 2070 of P{neo FRT} (the FBtp0000348 locus according to Fly-
Base). P{>whs>, FRT}42B was originally inserted 30 to the T at position
11497 of the AE003789 clone, with the 50 end of the P element closer
to the telomere. In clipped P{>whs>, FRT}42B, the 50 end of the P ele-
ment and one of the FRT repeats (bases 10–2821 of P{FRT(whs)}, the
FBtp0000268 locus according to FlyBase) were deleted. Because
the 50 region of the P element is necessary for transposition, neither
clipped P{hs-neo>>, ry+, FRT}40A nor clipped P{>whs>, FRT}42B
can be mobilized using P transposase. Nevertheless, the FRT se-
quences are fully functional for FLP-driven site-specific recombina-
tion. Due to the clipping off of the respective 50 regions of the P ele-
ments in the original chromosome, this new chromosome is termed
clipped FRT2L2R, or cFRT2L2R. After P element mutagenesis of this
chromosome, it is possible to generate local imprecise excision
events to create new alleles of the P element-induced mutation of
interest. Any such mutation induced on this chromosome can then
be examined for its behavior in homozygous recombinant clones
by the FLP-FRT site-specific recombination system. The cFRT2L2
chromosome is thus a useful tool for the systematic disruption
and subsequent analysis of more than 35% of the fly genome.
Transgenes
The 5.4 kb NcoI-BamHI T1 genomic fragment, the 3 kb SalI-SalI T2
genomic fragment, and the 4.3 kb EagI-BamHI T3 genomic fragment
from P1 clone DS06090 (obtained from the Berkeley Drosophila
Genome Project) were each subcloned into pCaSpeR4 for comple-
mentation analysis (Figure 1J). The T4 genomic fragment was
constructed by digestion of the T3 fragment with BsiWI followed
by Klenow treatment and self-ligation. This generates a frameshift
after the 11th amino acid in the N-terminal region of CG11183 in
T4. The T5 genomic fragment was constructed by digestion of the
T3 fragment with NheI followed by Klenow treatment and self-liga-
tion. This generates a frameshift after the NheI site which disrupts
the coding sequence of CG5602. The T2R57A fragment, which con-
tains an R to A substitution at amino acid 57 in dDcp (Figure 1J),
was generated using a QuikChange site-directed mutagenesis kit
(Stratagene). P{UASp-HA-dDcp1} and P{UASp-HA-N180-dDcp1}
were generated by introducing the N-terminal HA-tagged full-length
dDcp1 and an HA fusion of the N-terminal 180 amino acids of dDcp1,
respectively, into pUASp. The dDcp1 full-length coding sequence
was obtained from EST clone GH04763. To generate a YFP-dDcp1
fusion protein, the EYFP coding sequence (Clontech) was inserted
directly in front of the translational start site of dDcp1 in the 2.8 kb
SalI-XbaI genomic fragment subcloned from T2.
Northern Blot Analysis
Total RNAs were extracted from staged embryo collections at 1 hr
intervals from different dDcp1 genotypes using the Purescript RNA
Isolation kit (Gentra). DIG-labeled (Roche) osk, bcd, twe, and rp49
RNA probes were made by in vitro transcription using the DIG North-
ern Starter kit (Roche). Please see Supplemental Data for cloning
details of plasmids used for probe generation. Northern blot proce-
dures were carried out using the Dig application manual for filter
hybridization (Roche).
Antibody Generation and Immunochemistry
For dDcp1 antibody production, a peptide with the sequence SAPQ
QPKQDSSQPAS, corresponding to amino acid residues 140–154 of
dDcp1, was used to generate a polyclonal rabbit antiserum. For
dDcp2 antibody production, the coding sequence of the dDcp2
C-terminal 289 amino acids (subcloned from EST clone SD14939)
was cloned into the pRset vector for fusion protein expression and
antibody generation. The detailed Western blot analysis, immunoflu-
orescence staining, and coimmunoprecipitation protocols used are
provided in the Supplemental Data.
In Situ Hybridization
The detailed protocol used is provided in the Supplemental Data.Supplemental Data
Supplemental Data include a table, three figures, and Supplemen-
tal Experimental Procedures and are available at http://www.
developmentalcell.com/cgi/content/full/10/5/601/DC1/.
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